Compare VICI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICI | DGX |
|---|---|---|
| Founded | 2016 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 23.2B |
| IPO Year | 2017 | 1996 |
| Metric | VICI | DGX |
|---|---|---|
| Price | $25.51 | $237.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $33.75 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 5.5M | 751.7K |
| Earning Date | 04-29-2026 | 04-21-2026 |
| Dividend Yield | ★ 6.29% | 1.82% |
| EPS Growth | 1.95 | ★ 13.78 |
| EPS | 1.30 | ★ 5.08 |
| Revenue | $4,006,116,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $4.47 | $7.53 |
| Revenue Next Year | $1.67 | $3.77 |
| P/E Ratio | ★ $19.77 | $46.74 |
| Revenue Growth | 4.08 | ★ 11.78 |
| 52 Week Low | $25.34 | $171.18 |
| 52 Week High | $33.65 | $247.19 |
| Indicator | VICI | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 52.40 |
| Support Level | N/A | $232.28 |
| Resistance Level | $27.45 | $240.13 |
| Average True Range (ATR) | 0.38 | 4.80 |
| MACD | -0.05 | -1.44 |
| Stochastic Oscillator | 19.61 | 31.11 |
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.